Stock ScreenerStock IdeasBiotech BreakthroughsBest Biotech Stocks To Buy NowTop biotech stocks that analysts expect to be profitable within the next 3 years
Stock ScreenerStock IdeasBiotech Breakthroughs
Industry: Biotechnology
Forecast Earnings Growth: Positive
| Ticker | Company | Forecast Score | Market Cap | Price | Price Target | Upside/Downside | Top Analysts Upside/Downside | Consensus | Top Analysts Consensus | Analysts | Top Analysts | Fore. Revenue Growth | Fore. Earnings Growth | Forecast ROE | Forecast ROA |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| KRYS | KRYSTAL BIOTECH INC | $4.40B | $155.68 | $185.67 | 19.26% | Strong Buy | 6 | 104.18% | 52.91% | N/A | N/A | ||||
| TGTX | TG THERAPEUTICS INC | $2.15B | $13.91 | $30.20 | 117.11% | Strong Buy | 5 | 38.43% | 139.09% | N/A | N/A | ||||
| GMAB | GENMAB A | $18.14B | $27.46 | $45.00 | 63.87% | Buy | 4 | 21.76% | 48.09% | N/A | N/A | ||||
| INCY | INCYTE CORP | $11.49B | $51.18 | $74.69 | 45.94% | Buy | 13 | 11.30% | 52.77% | N/A | N/A | ||||
| BMRN | BIOMARIN PHARMACEUTICAL INC | $15.50B | $82.17 | $102.25 | 24.44% | Buy | 12 | 12.27% | 94.71% | N/A | N/A | ||||
| HRMY | HARMONY BIOSCIENCES HOLDINGS INC | $1.64B | $28.93 | $37.33 | 29.05% | Buy | 6 | 17.13% | 42.05% | N/A | N/A | ||||
| CORT | CORCEPT THERAPEUTICS INC | $2.30B | $22.21 | $39.33 | 77.10% | Strong Buy | 3 | 16.94% | 29.98% | N/A | N/A | ||||
| MDXG | MIMEDX GROUP INC | $917.76M | $6.25 | $12.67 | 102.83% | Strong Buy | 3 | 11.82% | 25.46% | N/A | N/A | ||||
| HALO | HALOZYME THERAPEUTICS INC | $4.88B | $38.46 | $54.17 | 40.84% | Buy | 6 | 15.95% | 48.53% | N/A | N/A | ||||
| RPRX | ROYALTY PHARMA PLC | $16.79B | $28.11 | $46.75 | 66.31% | Strong Buy | 4 | 11.31% | 34.87% | N/A | N/A | ||||
| VNDA | VANDA PHARMACEUTICALS INC | $257.77M | $4.48 | N/A | N/A | N/A | N/A | 13.15% | 102.06% | N/A | N/A | ||||
| TECH | BIO-TECHNE CORP | $9.85B | $62.66 | $78.43 | 25.17% | Strong Buy | 7 | 6.67% | 29.33% | N/A | N/A | ||||
| EXEL | EXELIXIS INC | $7.13B | $23.53 | $27.17 | 15.46% | Buy | 6 | 8.37% | 55.63% | N/A | N/A | ||||
| JAZZ | JAZZ PHARMACEUTICALS PLC | $6.70B | $107.43 | $193.09 | 79.74% | Strong Buy | 11 | 6.51% | 64.32% | N/A | N/A | ||||
| PBYI | PUMA BIOTECHNOLOGY INC | $235.25M | $4.88 | $7.00 | 43.44% | Buy | 1 | 0.26% | 31.88% | N/A | N/A | ||||
| BNTX | BIONTECH SE | $20.61B | $86.71 | $114.71 | 32.30% | Hold | 7 | -8.71% | 36.84% | N/A | N/A | ||||
| AMLX | AMYLYX PHARMACEUTICALS INC | $120.65M | $1.78 | $11.00 | 517.98% | Buy | 5 | -49.09% | 142.34% | N/A | N/A | ||||
| CPRX | CATALYST PHARMACEUTICALS INC | $1.73B | $14.68 | $27.40 | 86.65% | Strong Buy | 5 | 16.34% | 16.52% | N/A | N/A | ||||
| NVO | NOVO NORDISK A S | $567.31B | $125.79 | $133.00 | 5.73% | Strong Buy | 6 | 20.70% | 4.76% | N/A | N/A | ||||
| UTHR | UNITED THERAPEUTICS CORP | $11.10B | $235.95 | $298.00 | 26.30% | Strong Buy | 7 | 9.49% | 8.78% | N/A | N/A | ||||
| REGN | REGENERON PHARMACEUTICALS INC | $97.76B | $890.68 | $1.00k | 12.78% | Buy | 16 | 7.40% | 4.84% | N/A | N/A | ||||
| VRTX | VERTEX PHARMACEUTICALS INC | $102.73B | $397.70 | $451.75 | 13.59% | Buy | 16 | 8.93% | 2.45% | N/A | N/A |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.